Electric-vehicle maker Tesla and traditional auto manufacturers General Motors and Ford fall but claw back losses with the ...
Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.
IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...
IDEXX Laboratories, Inc. (IDXX) is up by 11.55 percent during Friday morning trading, following the release of its fourth-quarter ...
IDEXX Laboratories, Inc.’s IDXX share price has surged by 11.13%, which has investors questioning if this is right time to ...
IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...
While reporting financial results for the fourth quarter on Monday, pet healthcare provider IDEXX Laboratories, Inc. (IDXX) initiated ...
Idexx forecast revenue between $4.06 billion and $4.17 billion in 2025, in line with analysts' estimates of $4.14 billion. The company also guided for earnings per share in the range of $11.74 and $12 ...
Idexx Laboratories stock was rising sharply Monday, even as the S&P 500 and major indexes remained in the red. The Dow Jones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback